Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Y Jeremy

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|December 2, 2004
Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right-heart dysfunction, and refractory hypoxemia after cardiothoracic surgerySaima Muzaffar, Nilima Shukla, Gianni D Angelini, et al.
Journal of Cellular Physiology|July 7, 2011
NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cellsSaima Muzaffar, Jamie Y Jeremy, Gianni D Angelini, et al.
European Journal of Pharmacology|May 2, 2006
Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprostSaima Muzaffar, Nilima Shukla, Gianni D Angelini, et al.
British Journal of Pharmacology|April 27, 2005
Prednisolone augments superoxide formation in porcine pulmonary artery endothelial cells through differential effects on the expression of nitric oxide synthase and NADPH oxidaseSaima Muzaffar, Nilima Shukla, Gianni D Angelini, et al.
European Journal of Pharmacology|June 12, 2013
Low nanomolar thapsigargin inhibits the replication of vascular smooth muscle cells through reversible endoplasmic reticular stressNilima Shukla, Song Wan, Gianni D Angelini, et al.
Pharmacological Research|November 9, 2010
Endothelin-1 (ET-1) and vein graft failure and the therapeutic potential of ET-1 receptor antagonistsJamie Y Jeremy, Nilima Shukla, Gianni D Angelini, et al.
Cardiovascular Research|January 29, 2014
Interactions between thromboxane A₂, thromboxane/prostaglandin (TP) receptors, and endothelium-derived hyperpolarizationDavid C Ellinsworth, Nilima Shukla, Ingrid Fleming, et al.
BJU International|May 27, 2010
8-isoprostane F2α up-regulates the expression of type 5 phosphodiesterase in cavernosal vascular smooth muscle cells: inhibition with sildenafil, iloprost, nitric oxide and picotamideMatthew Hotston, Jamie Y Jeremy, Raj Persad, et al.
Journal of Cardiac Surgery|January 28, 2003
Oxidative stress, nitric oxide, and vascular diseaseJamie Y Jeremy, Anthony P Yim, Song Wan, et al.
BJU International|November 28, 2006
Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptomsMatthew Hotston, Nilima Shukla, Jonathon Bloor, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Thoracic and Cardiovascular Surgery|December 2, 2004
Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right-heart dysfunction, and refractory hypoxemia after cardiothoracic surgerySaima Muzaffar, Nilima Shukla, Gianni D Angelini, et al.
Journal of Cellular Physiology|July 7, 2011
NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cellsSaima Muzaffar, Jamie Y Jeremy, Gianni D Angelini, et al.
European Journal of Pharmacology|May 2, 2006
Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprostSaima Muzaffar, Nilima Shukla, Gianni D Angelini, et al.
British Journal of Pharmacology|April 27, 2005
Prednisolone augments superoxide formation in porcine pulmonary artery endothelial cells through differential effects on the expression of nitric oxide synthase and NADPH oxidaseSaima Muzaffar, Nilima Shukla, Gianni D Angelini, et al.
European Journal of Pharmacology|June 12, 2013
Low nanomolar thapsigargin inhibits the replication of vascular smooth muscle cells through reversible endoplasmic reticular stressNilima Shukla, Song Wan, Gianni D Angelini, et al.
Pharmacological Research|November 9, 2010
Endothelin-1 (ET-1) and vein graft failure and the therapeutic potential of ET-1 receptor antagonistsJamie Y Jeremy, Nilima Shukla, Gianni D Angelini, et al.
Cardiovascular Research|January 29, 2014
Interactions between thromboxane A₂, thromboxane/prostaglandin (TP) receptors, and endothelium-derived hyperpolarizationDavid C Ellinsworth, Nilima Shukla, Ingrid Fleming, et al.
BJU International|May 27, 2010
8-isoprostane F2α up-regulates the expression of type 5 phosphodiesterase in cavernosal vascular smooth muscle cells: inhibition with sildenafil, iloprost, nitric oxide and picotamideMatthew Hotston, Jamie Y Jeremy, Raj Persad, et al.
Journal of Cardiac Surgery|January 28, 2003
Oxidative stress, nitric oxide, and vascular diseaseJamie Y Jeremy, Anthony P Yim, Song Wan, et al.
BJU International|November 28, 2006
Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptomsMatthew Hotston, Nilima Shukla, Jonathon Bloor, et al.
Pageof 6